ARCHIVES

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

This article is from The Cancer Letter archive.

Vol. 02 No. 40 | October 1, 1976

Download PDF Visit The Full Archive

Related Articles

In Brief: Community ASSN. Developing Clinical Standards Catalogue; Perry Leaves NCI For NIH Position

November 15, 1974

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

Center Grant Review Tougher, Yarbro Insists

May 23, 1975

ASCO President Criticizes Use Of Cooperative Agreement in Clinical Trials

May 18, 1984

In Brief: Columbia Still In Running As Comprehensive Center In ’78; Illinois Withdraws Application

June 24, 1977

Text of PDQ Statement on Breast Screening

September 17, 1993